Although stem cell transplantation after ischemic stroke has been extensively tested as a possible therapy in adult animals, little research has been done to evaluate stem cell transplantation in neonates. Among the different types of stem cells, bone marrow mesenchymal stem cells (BMSCs) are unique in their potential for multipotentcy and their autograft capability. BMSCs are capable of passing through the blood brain barrer and homing to the ischemic region. The low survival rate of transplanted BMSCs, or stem cells in general, however, has significantly hampered their effectiveness and application in stroke therapy. Making use of our unique barrel cortex ischemic stroke model in the neonate, we will pursue novel approaches to improve both the viability and regenerative capacity of BMSCs.
Specific Aim 1 will test the hypothesis that transplantation of BMSCs pre-treated with hypoxic preconditioning (HP) will result in significantly greater functional benefits in the repair of the ischemia- damaged cortex than non-treated BMSCs. Further improvement of functional benefits will be achieved through an enriched environment of target specific physical therapy following BMSC transplantation.
Specific Aim 2 will examine the hypothesis that HP-pretreatment of BMSCs significantly enhances their survival after transplantation into the neonatal ischemic brain. The extent of cell death and neural differentiation of BMSCs that home to the ischemic cortex will be compared at 1 to 30 days after transplantation.
Specific Aim 3 will examine the effect of transplanted BMSCs on angiogenesis in the post-ischemic brain. We will specifically test the novel hypothesis that HP-increased VEGF expression in BMSCs is a potent stimulator of endogenous angiogenesis, neurogenesis and therefore is effective in the treatment of ischemic stroke. Recovery of local cerebral blood flow (LCBF) and barrel functions after BMSC treatment will be correlated with both angiogenesis and morphological changes. We expect that this novel therapeutic intervention combining 1) administation of HP-BMSCs with 2) an enriched environment, will result in synergistic beneficial effects;if so, this strategy will likely improve the efficacy and efficiency of BMSC transplantation therapy in the treatment of stroke in adults as well as in neonates.
A combination strategy will be tested to improve the cell survival quality and regenerative capacities of transplanted bone marrow mesenchymal stem cells (BMSCs) after rat neonatal ischemic stroke. We will address three key issues in BMSC transplantation: 1) to promote survival of BMSCs after transplantation;2) to promote endogenous regenerative responses;3) to guide and improve the repair process and functional recovery in the whisker-barrel pathway after BMSC transplantation.
|Zhao, Yingying; Wei, Zheng Zachory; Zhang, James Ya et al. (2017) GSK-3? Inhibition Induced Neuroprotection, Regeneration, and Functional Recovery After Intracerebral Hemorrhagic Stroke. Cell Transplant 26:395-407|
|Wei, Ling; Wei, Zheng Z; Jiang, Michael Qize et al. (2017) Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke. Prog Neurobiol 157:49-78|
|Lee, Jin Hwan; Espinera, Alyssa R; Chen, Dongdong et al. (2016) Neonatal inflammatory pain and systemic inflammatory responses as possible environmental factors in the development of autism spectrum disorder of juvenile rats. J Neuroinflammation 13:109|
|Lee, Jin Hwan; Wei, Ling; Deveau, Todd C et al. (2016) Expression of the NMDA receptor subunit GluN3A (NR3A) in the olfactory system and its regulatory role on olfaction in the adult mouse. Brain Struct Funct 221:3259-73|
|Wei, Zheng Zachory; Lee, Jin Hwan; Zhang, Yongbo et al. (2016) Intracranial Transplantation of Hypoxia-Preconditioned iPSC-Derived Neural Progenitor Cells Alleviates Neuropsychiatric Defects After Traumatic Brain Injury in Juvenile Rats. Cell Transplant 25:797-809|
|Lee, Jin Hwan; Wei, Zheng Z; Chen, Dongdong et al. (2015) A neuroprotective role of the NMDA receptor subunit GluN3A (NR3A) in ischemic stroke of the adult mouse. Am J Physiol Cell Physiol 308:C570-7|
|Sun, Jinmei; Wei, Zheng Zachory; Gu, Xiaohuan et al. (2015) Intranasal delivery of hypoxia-preconditioned bone marrow-derived mesenchymal stem cells enhanced regenerative effects after intracerebral hemorrhagic stroke in mice. Exp Neurol 272:78-87|
|Woodbury, Anna; Yu, Shan Ping; Chen, Dongdong et al. (2015) Honokiol for the Treatment of Neonatal Pain and Prevention of Consequent Neurobehavioral Disorders. J Nat Prod 78:2531-6|
|Chen, Dongdong; Lee, Jinhwan; Gu, Xiaohuan et al. (2015) Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice. ASN Neuro 7:|
|Liu, Xian-Bao; Wang, Jian-An; Ji, Xiao-Ya et al. (2014) Preconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of rats. Stem Cell Res Ther 5:111|
Showing the most recent 10 out of 36 publications